Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 40, 2021 - Issue 5
296
Views
9
CrossRef citations to date
0
Altmetric
Original Investigation

Natural history of inflammatory and non-inflammatory dry eye in thyroid eye disease

ORCID Icon, ORCID Icon & ORCID Icon
Pages 389-393 | Received 08 Jun 2020, Accepted 19 Aug 2020, Published online: 26 Aug 2020

References

  • Shan SJC, Douglas RS. The pathophysiology of thyroid eye disease. J Neuroophthalmol. 2014;34(2):177–185. doi:10.1097/WNO.0000000000000132.
  • Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A. van der Gaag R. Clinical criteria for the assessment of disease activity in Graves’ ophthalmopathy: a novel approach. Br J Ophthalmol. 1989;73(8):639–644. doi:10.1136/bjo.73.8.639.
  • Gürdal C, Saraç O, Genç I, Kırımlıoğlu H, Takmaz T, Can I. Ocular surface and dry eye in Graves’ disease. Curr Eye Res. 2011;36(1):8–13. doi:10.3109/02713683.2010.526285.
  • Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118(9):1264–1268. doi:10.1001/archopht.118.9.1264.
  • Selter JH, Gire AI, Sikder S. The relationship between Graves’ ophthalmopathy and dry eye syndrome. Clin Ophthalmol. 2015;9:57–62. doi:10.2147/OPTH.S76583.
  • Huang D, Xu N, Song Y, Wang P, Yang H. Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy. Graefes Arch Clin Exp Ophthalmol. 2012;250(4):619–625. doi:10.1007/s00417-011-1863-x.
  • Bruscolini A, Abbouda A, Locuratolo N, Restivo L, Trimboli P, Romanelli F. Dry eye syndrome in non-exophthalmic Graves’ disease. Semin Ophthalmol. 2015;30(5–6):372–376. doi:10.3109/08820538.2013.874491.
  • Dolman PJ. Grading severity and activity in thyroid eye disease. Ophthal Plast Reconstr Surg. 2018;34(4S Suppl 1):S34–S40. doi:10.1097/IOP.0000000000001150.
  • Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118(5):615–621. doi:10.1001/archopht.118.5.615.
  • Walt JRM. Evaluating the functional impact of dry eye: the ocular surface disease index. Drug Inf J. 1997;31:1436.
  • Terwee CB, Gerding MN, Dekker FW, Prummel MF, Wiersinga WM. Development of a disease specific quality of life questionnaire for patients with Graves’ ophthalmopathy: the GO-QOL. Br J Ophthalmol. 1998;82(7):773–779. doi:10.1136/bjo.82.7.773.
  • Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin Endocrinol. 1997;47(1):9–14. doi:10.1046/j.1365-2265.1997.2331047.x.
  • Nowak M, Marek B, Kos-Kudła B, Kajdaniuk D, Siemińska L. Tear film profile in patients with active thyroid orbithopathy. Klin Oczna. 2005;107:479–482.
  • Gilbard JP, Farris RL. Ocular surface drying and tear film osmolarity in thyroid eye disease. Acta Ophthalmol. 1983;61(1):108–116. doi:10.1111/j.1755-3768.1983.tb01401.x.
  • Ozkan SB, Söylev MF, Vahapoglu H, Can D, Arsan AK, Duman S. Evaluation of conjunctival morphology in thyroid associated eye disease by use of impression cytology. Acta Ophthalmol Scand. 1997;75(2):145–147. doi:10.1111/j.1600-0420.1997.tb00111.x.
  • The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye workshop (2007). Ocul Surf. 2007;5(2):75–92. doi:10.1016/S1542-0124(12)70081-2.
  • Tsubota K, Yokoi N, Shimazaki J, Watanabe H, Dogru M, Yamada M, et al. New perspectives on dry eye definition and diagnosis: a consensus report by the Asia dry eye society. Ocul Surf. 2017;15(1):65–76. doi:10.1016/j.jtos.2016.09.003.
  • Enríquez-de-Salamanca A, Calonge M. Cytokines and chemokines in immune-based ocular surface inflammation. Expert Rev Clin Immunol. 2008;4(4):457–467. doi:10.1586/1744666X.4.4.457.
  • Rhee MK, Mah FS. Inflammation in dry eye disease: how do we break the cycle? Ophthalmology. 2017;124(11S):S14–S19. doi:10.1016/j.ophtha.2017.08.029.
  • Gumus K, Cavanagh DH. The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca. Clin Ophthalmol. 2009;3:57–67.
  • Yamaguchi T. Inflammatory response in dry eye. Invest Ophthalmol Vis Sci. 2018;59(14):DES192–DES199. doi:10.1167/iovs.17-23651.
  • Eckstein AK, Finkenrath A, Heiligenhaus A, Renzing-Kohler K, Esser J, Kruger C, et al. Dry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies. Acta Ophthalmol Scand. 2004;82(3 Pt 1):291–297. doi:10.1111/j.1395-3907.2004.00268.x.
  • Khalil HA, De Keizer RJ, Bodelier VM, Kijlstra A. Secretory IgA and lysozyme in tears of patients with Graves’ ophthalmopathy. Doc Ophthalmol. 1989;72(3–4):329–334. doi:10.1007/BF00153500.
  • Ujhelyi B, Gogolak P, Erdei A, Nagy V, Balazs E, Rajnavolgyi E, et al. Graves’ orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines. Thyroid. 2012;22(4):407–414. doi:10.1089/thy.2011.0248.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.